The government's push for a change in the method of price calculation methodology for new drugs can lead to non-essential drugs coming under price control, a senior pharma industry body executive said.
Chemicals and Fertilisers ministry in a statement issued last week had said that the Department of Pharmaceuticals (DoP) is considering a change in the method of approving prices of new drugs.
"This proposal relates to doing away with retail price by ceiling price for 'new drugs'. It has potential to bring non- essential drugs under price control, reduce competition and compromise growth," Indian Pharmaceutical Alliance (IPA) Secretary General D G Shah told
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)